Treatment and outcomes of eastern Europeans with coronary syndromes in OPUS-TIMI 16

International Journal of Cardiology

Volumn 100, Issue 1, 2005, Pages 101-107

  Gurjeva, Olga S ^b   Bukhman, Gene ^a   Murphy, Sabina ^c   Cannon, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Institute of Cardiology   (Ukraine)

^c HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Acute coronary syndromes; Eastern Europe; Geographic variation; Medical management; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; NITRATE; ORBOFIBAN; NITRIC ACID DERIVATIVE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; EASTERN EUROPE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ACUTE CORONARY SYNDROME; CLINICAL FEATURE; CZECH REPUBLIC; EASTERN EUROPEAN; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HUNGARY; MULTICENTER STUDY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; POLAND; RANDOMIZED CONTROLLED TRIAL; RUSSIAN FEDERATION; ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; TREATMENT DURATION;

EID: 16844378035     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.08.075     Document Type: Article

References (24)

1. M. Bobak, and M. Marmot East-west mortality divide and its potential explanations proposed research agenda BMJ 312 1996 421 425
2. A. Velkova, J.H.W.-Vd. Bosch, and J.P. MacKenbach The east-west life expectancy gap: differences in mortality form conditions amenable to medical intervention Int. J. Epidemiol. 26 1997 75 84
3. M.G. Field, D.M. Kotz, and G. Bukhman Neoliberal economic policy, "state desertion," and the Russian health crisis J.Y. Kim J.V. Millen A. Irwin J. Gershman Dying for growth: global inequality and the health of the poor 2000 Common Courage Press Monroe, ME 155 176
4. World Health Organization Health for all. Statistical database for personal computer 2002 WHO Office for Europe Copenhagen
5. H. Tunstall-Pedoe, D. Vanuzzo, and M. Hobbs Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA project populations Lancet 355 2000 688 700
6. K. Fox, S. Goodman, W. Klein for the Grace Investigators Management of acute coronary syndromes. Variations in practice and outcome. Findings from the global registry of acute coronary events (GRACE) Eur. Heart J. 23 2002 1177 1189
7. C.P. Cannon, C.H. McCabe, and R.G. Wilcox Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial Circulation 102 2000 149 156
8. ACC/AHA Task Force on Practice Guidelines ACC/AHA guidelines for the management of patients with acute myocardial infarction J. Am. Coll. Cardiol. 28 1996 1328 1428
9. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Acute myocardial infarction: pre-hospital and in-hospital management Eur. Heart J. 17 1996 43 53
10. E. Braunwald Diagnosing and managing unstable angina. Agency for health care policy and research Circulation 90 1994 613 622
11. K.A. Fox, D. Cokkinos, J. Deckers, U. Keil, A. Maggioni, and G. Steg The ENACT study: a pan-European survey of acute coronary syndromes. European network for acute coronary treatment Eur. Heart J. 21 2000 1440 1449
12. D. Hasdai, S. Behar, and L. Wallentin A prospective survey of the characteristics, treatments, and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin Eur. Heart J. 23 2002 1190 1201
13. K. Eagle, S. Goodman, A. Avezum, A. Budaj, C. Sullivan, and J. Lopez-Sendon Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the global registry of acute coronary events (GRACE) Lancet 359 2002 373 377
14. S. Windecker, and W. Maier-Rudolph Interventional cardiology in Europe 1995 Eur. Heart J. 20 1999 484 495
15. L. Piegas, M. Flather, and J. Pogue The organization to assess strategies for ischemic syndromes (OASIS) registry in patients with unstable angina Am. J. Cardiol. 84 1999 7M 12M
16. R. Giugliano, J. Llevadot, and R. Wilcox Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II Eur. Heart J. 22 2001 1702 1715
17. ACC/AHA Task Force on Practice Guidelines ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article Circulation 106 2002 1893 1900
18. ACC/AHA Task Force on Practice Guidelines 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations Circulation 100 1999 1016 1030
19. The PURSUIT Trial Investigators Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes N. Engl. J. Med. 339 1998 436 443
20. EUROASPIRE II Group Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Eur. Heart J. 22 2001 554 572
21. EUROASPIRE I and II Group Clinical reality of coronary prevention guidelines: comparison of EUROASPIRE I and II in nine countries Lancet 357 2001 995 1001
22. M. Bobak, Z. Skodova, Z. Pisa, R. Polene, and M. Marmot Political changes and trends in cardiovascular risk factors in Czech Republic, 1985-1992 J. Epidemiol. Community Health 51 1997 272 277
23. W. Zatonski, A. McMicheal, and J. Powles Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991 BMJ 316 1998 1047 1051
24. C. Cannon, and M. Bahit Underutilization of evidence-based medications in acute ST elevation myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 9 registry Crit. Pathw. Cardiol. 1 2002 44 52